USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke TRIST wurde als Wortmarke am 14.06.2007 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 10.03.2009 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "IR CANCELLED; US REGISTRATION CANCELLED".
| Markenform | Wortmarke |
| Aktenzeichen | 79043527 |
| Registernummer | 3587260 |
| Anmeldedatum | 14. Juni 2007 |
| Veröffentlichungsdatum | 23. Dezember 2008 |
| Eintragungsdatum | 10. März 2009 |
Markeninhaber
Robert Robinson Avenue,; The Oxford Scie nce Park; Oxford OX4 4GA
Markenvertreter
Waren und Dienstleistungen
1
Chemicals for use in industry and science, namely, enzymes for scientific and research purposes; chemical products for in-vitro use in laboratories and for analysis, namely, enzymes and chemicals for use in gene delivery technology for laboratory and research use; micro-organisms for laboratory and research use, cell cultures for laboratory and research use, plasmids and cultures of micro organisms for laboratory and research use, deoxyribonucleic acid sequences for laboratory and research use, cloning vehicles, namely, chemical preparations for scientific purposes for use in biotechnology, research and development and recombinant deoxyribonucleic acid variations thereof for laboratory and research use, all for in-vivo use
5
Gene therapy and prophylaxis products, namely, gene delivery pharmaceuticals; pharmaceuticals for the delivery of genes to muscle cells, all for medical purposes; vaccines, enzymes, and enzyme preparations for the treatment of cancer; hypoxia response pharmaceutical substances and preparations, viral and retroviral vectors, viral and retroviral vector manufacturing preparations for the treatment of cancer; pharmaceutical and biochemical preparations for the treatment of cancer
10
Instruments and apparatus for the administration of gene therapy vaccines and prophylaxis preparations and substances and pre-filled vials, syringes and injectors containing pharmaceuticals for the treatment of cancer sold as a unit
42
Scientific and medical research and development; genetic engineering services for scientific purposes; biotechnology services, namely, research and development in the field of biotechnology and providing information on the subject of scientific research in the field of biotechnology; scientific advisory services relating to gene therapy products and clinical trials, conducting clinical trials
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1379043527